Engineering a packaging nanomotor for delivery of RNA and other molecules
设计用于递送 RNA 和其他分子的包装纳米马达
基本信息
- 批准号:7904763
- 负责人:
- 金额:$ 16.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAffinity ChromatographyAgar Gel ElectrophoresisArginineBacteriophage T4BiologicalBiological AssayCellsChargeComputer Systems DevelopmentDNADNA Groove BindingDNA PackagingDataDevicesDouble-Stranded RNAEngineeringFingersFoundationsFrequenciesGoalsHybridsIn VitroInfectionMeasurementMotorMutagenesisMutationNucleic AcidsPeptidesPharmacotherapyProteinsRNARestRoentgen RaysSchemeSepharoseShapesSolutionsSpecificityStructural BiochemistryStructural ModelsStructureSubstrate SpecificitySystemTestingTherapeuticVariantVertebral columnViral Packagingdesignds-DNAhigh throughput screeningimprovedinorganic phosphateinterestlaser tweezermutantnanobiotechnologynanomachinenovelnucleaseoverexpressionpublic health relevancesingle moleculetranslocase
项目摘要
DESCRIPTION (provided by applicant): One of the biggest challenges in nanobiotechnology is to engineer a biological component to carry out a specific task. The goal of this application is to engineer the bacteriophage T4 DNA packaging motor to translocate double stranded RNA and RNA:DNA hybrid molecules. The ability to alter the translocation specificity of the motor will greatly enhance its potential as a delivery nanomachine; adapting the existing machinery to transport a therapeutic molecule of interest into cells. The X-ray and cryo-EM structures of the phage T4 packaging motor have been recently determined. The motor protein, gp17, consists of several parts; ATPase (the engine), translocase (the wheel) and arginine finger (the spark plug). The translocation specificity is determined by a DNA binding groove that is well- separated from the rest of the motor. The shape and size of the groove fit a double stranded DNA molecule, and the distribution of positively charged residues lining the groove follows the pitch of the double helix; interacting with the backbone phosphates. These features suggest that the packaging motor is amendable to design novel motors with altered specificity. The translocation groove of gp17 will be mutagenized by error-prone and overlap extension PCR to introduce ~3 mutations per groove. Hundreds, if not thousands, of variants will be screened for the ability to translocate RNA in a high-throughput format. The his-tagged mutants will be overexpressed in E.coli and purified by affinity chromatography using 96-well Ni-Sepharose plates. An established defined in vitro packaging assay consisting of purified proheads, the packaging motor, ATP, and nucleic acid will be used to rapidly screen for RNA translocation mutants. This assay assembles the packaging machine in solution, and translocation into proheads is assessed by the presence of nuclease-protected RNA following agarose gel electrophoresis. The simplicity of this system lends itself well to the high-throughput format, allowing hundreds of mutant proteins and several different nucleic acids to be tested. The gp17 RNA translocation mutants identified in the high-throughput screen will be purified and analyzed for packaging ATPase, efficiency, and substrate specificity. Structural modeling of the mutant translocation grooves will be guided by the already determined crystal structures of the motor protein and its domains. Single molecule studies will be performed using optical tweezers to analyze motor dynamics; force, power, and rate, as well as frequency of slips or pauses; identifying subtle mechanistic differences between DNA and RNA translocation. Together, these findings will establish the design principles for further engineering of the motor to improve specificity and/or efficiency of RNA translocation. The proof of principle data generated from this application will provide a broader foundation for the application of the phage T4 packaging motor as a versatile nanomachine.
PUBLIC HEALTH RELEVANCE: A major challenge in nanobiotechnology is the ability to engineer new or improved biological devices for a specific purpose. The current application aims to use an established scheme of mutagenesis, biochemistry, structural analysis, and biophysical measurements and apply it to the design of a novel nanomachine from a well-defined viral packaging motor. This project will provide proof of principle data for the development of this system into a versatile delivery vehicle, delivering DNA, RNA, peptide, or drug therapy into the cell.
描述(由申请人提供):纳米生物技术的最大挑战之一是设计生物组件来执行特定任务。本申请的目标是设计噬菌体T4 DNA包装马达以易位双链RNA和RNA:DNA杂交分子。改变马达的易位特异性的能力将极大地增强其作为递送纳米机器的潜力;调整现有的机器以将感兴趣的治疗分子运输到细胞中。最近已经确定了噬菌体T4包装马达的X射线和冷冻电镜结构。运动蛋白gp 17由几个部分组成:ATP酶(发动机),转位酶(车轮)和精氨酸指(火花塞)。易位特异性由与马达的其余部分良好分离的DNA结合沟决定。凹槽的形状和大小适合双链DNA分子,并且凹槽内带正电荷的残基的分布遵循双螺旋的螺距;与骨架磷酸相互作用。这些特征表明,包装电机可用于设计具有改变的特异性的新型电机。gp 17的易位沟将通过易错和重叠延伸PCR诱变,以每个沟引入~3个突变。将筛选数百种(如果不是数千种)变体以高通量形式易位RNA的能力。His标记的突变体将在大肠杆菌中过表达,并使用96孔Ni-Sepharose平板通过亲和色谱法纯化。将使用由纯化的proheads、包装马达、ATP和核酸组成的已确定的体外包装试验快速筛选RNA易位突变体。该测定在溶液中组装包装机,并通过琼脂糖凝胶电泳后核酸酶保护的RNA的存在来评估向proheads中的易位。该系统的简单性使其适合高通量格式,允许测试数百种突变蛋白和几种不同的核酸。将纯化在高通量筛选中鉴定的gp 17 RNA易位突变体,并分析包装ATP酶、效率和底物特异性。突变易位槽的结构建模将由已经确定的马达蛋白及其结构域的晶体结构指导。单分子研究将使用光镊进行,以分析电机动力学;力,功率和速率,以及滑动或暂停的频率;识别DNA和RNA易位之间的细微机械差异。总之,这些发现将为进一步工程化马达以提高RNA易位的特异性和/或效率建立设计原则。从该应用中产生的原理数据的证明将为噬菌体T4包装马达作为多功能纳米机器的应用提供更广泛的基础。
公共卫生相关性:纳米生物技术的一个主要挑战是为特定目的设计新的或改进的生物设备的能力。本申请旨在使用诱变、生物化学、结构分析和生物物理测量的既定方案,并将其应用于从明确定义的病毒包装马达设计新型纳米机器。该项目将为将该系统开发为多功能递送载体提供原理数据证明,将DNA,RNA,肽或药物治疗递送到细胞中。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Venigalla B. Rao其他文献
T4DNAパッケージング蛋白質gp16およびgp17の相互作用の解析
T4DNA包装蛋白gp16和gp17之间的相互作用分析
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
藤田大悟;金丸周司;Venigalla B. Rao;有坂文雄 - 通讯作者:
有坂文雄
Effect of ATPase-Defective Mutant Doping on Functionality and Dynamics of Single Bacteriophage T4 DNA Packaging Motors
- DOI:
10.1016/j.bpj.2020.11.398 - 发表时间:
2021-02-12 - 期刊:
- 影响因子:
- 作者:
Suoang Lu;Vishal I. Kottadiel;Li Dai;Digvijay Singh;Taekjip Ha;Venigalla B. Rao;Yann R. Chemla - 通讯作者:
Yann R. Chemla
Regulation of a Viral Packaging Motor's Grips on DNA
- DOI:
10.1016/j.bpj.2017.11.542 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Mariam Ordyan;Douglas E. Smith;Venigalla B. Rao;Istiaq Alam;Marthandan Mahalingam - 通讯作者:
Marthandan Mahalingam
Analyzing DNA Packaging Initiation of Bacteriophage T4 by a Real-Time Single Molecule Fluorescence Assay
- DOI:
10.1016/j.bpj.2011.11.3497 - 发表时间:
2012-01-31 - 期刊:
- 影响因子:
- 作者:
Reza Vafabakhsh;Kiran Kondabagil;Li Dai;Zhihong Zhang;Venigalla B. Rao;Taekjip Ha - 通讯作者:
Taekjip Ha
Venigalla B. Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Venigalla B. Rao', 18)}}的其他基金
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications
噬菌体T4基因组流动的结构机制及其生物医学应用
- 批准号:
10635661 - 财政年份:2023
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
8819513 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
9000614 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
8694624 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8494569 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8685883 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8868023 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8410257 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display
使用噬菌体 T4 展示多价鼠疫、炭疽疫苗
- 批准号:
8435493 - 财政年份:2009
- 资助金额:
$ 16.18万 - 项目类别:
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display
使用噬菌体 T4 展示多价鼠疫、炭疽疫苗
- 批准号:
7644596 - 财政年份:2009
- 资助金额:
$ 16.18万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 16.18万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 16.18万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 16.18万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 16.18万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 16.18万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 16.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 16.18万 - 项目类别:
Collaborative Research and Development Grants